Are GLP-1 drugs for everyone?

Recent research highlights the emerging health benefits of GLP-1 drugs, traditionally used to treat diabetes and obesity, beyond their primary purposes. Scientists are now exploring their potential in tackling other conditions, sparking a debate about whether these medications could soon be prescribed for a wider range of ailments. This development is significant as it could revolutionize treatment approaches and improve health outcomes for many people. The implications extend to healthcare accessibility and the evolving landscape of pharmaceutical innovation.